| Amanda Mason, CRNP | |
|
2337 Homer Clayton Dr, Guntersville, AL 35976-2205 | |
| (256) 582-5131 | |
| Not Available |
| Full Name | Amanda Mason |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 9 Years |
| Location | 2337 Homer Clayton Dr, Guntersville, Alabama |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265893952 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 1135505 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Marshall Medical Centers | Boaz, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lakeside Clinic Llc | 8628980034 | 10 |
News Archive
Researchers from Kumamoto University, Japan have proposed that cellular senescence variations during the aging process could lead to control of health and onset of age-related diseases.
XTL Biopharmaceuticals Ltd., a biopharmaceutical development company, announced on November 21st that it has acquired 4,620,356 shares, of Proteologics Ltd., from Teva Pharmaceutical Industries Ltd. in consideration for an amount of approximately NIS 6.5 million, which represents an amount of NIS 1.405 per Share (approximately 22% premium).
New Australian research has shown how the immune system avoids attacking its own tissues with antibodies - whilst still maintaining a strong defence against invaders.
Mild cognitive impairment (MCI) is under the pharma' spotlight as the number of clinical trials currently underway has increased significantly during the past 12 months and the search for treatments that will prevent the progression of MCI to dementia continues. Synexus has teamed up with dementia expert, Dr Roger Bullock, to develop more effective clinical trials for this field.
› Verified 8 days ago
| Entity Name | Lakeside Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477657823 PECOS PAC ID: 8628980034 Enrollment ID: O20031104000389 |
News Archive
Researchers from Kumamoto University, Japan have proposed that cellular senescence variations during the aging process could lead to control of health and onset of age-related diseases.
XTL Biopharmaceuticals Ltd., a biopharmaceutical development company, announced on November 21st that it has acquired 4,620,356 shares, of Proteologics Ltd., from Teva Pharmaceutical Industries Ltd. in consideration for an amount of approximately NIS 6.5 million, which represents an amount of NIS 1.405 per Share (approximately 22% premium).
New Australian research has shown how the immune system avoids attacking its own tissues with antibodies - whilst still maintaining a strong defence against invaders.
Mild cognitive impairment (MCI) is under the pharma' spotlight as the number of clinical trials currently underway has increased significantly during the past 12 months and the search for treatments that will prevent the progression of MCI to dementia continues. Synexus has teamed up with dementia expert, Dr Roger Bullock, to develop more effective clinical trials for this field.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amanda Mason, CRNP 2337 Homer Clayton Dr, Guntersville, AL 35976-2205 Ph: (256) 582-5131 | Amanda Mason, CRNP 2337 Homer Clayton Dr, Guntersville, AL 35976-2205 Ph: (256) 582-5131 |
News Archive
Researchers from Kumamoto University, Japan have proposed that cellular senescence variations during the aging process could lead to control of health and onset of age-related diseases.
XTL Biopharmaceuticals Ltd., a biopharmaceutical development company, announced on November 21st that it has acquired 4,620,356 shares, of Proteologics Ltd., from Teva Pharmaceutical Industries Ltd. in consideration for an amount of approximately NIS 6.5 million, which represents an amount of NIS 1.405 per Share (approximately 22% premium).
New Australian research has shown how the immune system avoids attacking its own tissues with antibodies - whilst still maintaining a strong defence against invaders.
Mild cognitive impairment (MCI) is under the pharma' spotlight as the number of clinical trials currently underway has increased significantly during the past 12 months and the search for treatments that will prevent the progression of MCI to dementia continues. Synexus has teamed up with dementia expert, Dr Roger Bullock, to develop more effective clinical trials for this field.
› Verified 8 days ago
Hollie Lane Sims, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 38 Rowe Dr, Guntersville, AL 35976 Phone: 256-571-8460 | |
Miss Jennifer Lynn Sanders, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: Marshall Medical Center North, 8000 Alabama Hwy 69, Guntersville, AL 35976 Phone: 256-571-8108 | |
Mr. John Paul Mizelle, CRNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2017 Obrig Ave, Guntersville, AL 35976 Phone: 256-582-2324 | |
John Grimes, CRNP Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 7938 Al Hwy 69, Suite 100, Guntersville, AL 35976 Phone: 256-571-8445 Fax: 256-571-8447 | |
Mrs. Jessica Wallace Howard, MSN, AGNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 55 Rowe Dr, Suite C, Guntersville, AL 35976 Phone: 256-571-8807 | |
Katie Giles, WHNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 55 Rowe Dr Ste A, Guntersville, AL 35976 Phone: 256-571-8470 Fax: 256-571-8474 | |
Cathy Dawn Eubanks, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1241 Blount Ave, Guntersville, AL 35976 Phone: 256-582-6377 Fax: 256-582-6377 |